Core Medtech snaps up RMB 100m in Series A



Shenzhen Core Medtech Science & Technology Co., Ltd (GBI translation), an active medical implant start-up based in the Great Bay Area, reportedly raised nearly RMB 100 million (USD 14.83 million) via a Series A financing round. New Alliance Capital led the funding and Puhua Capital and Efung Capital participated. Proceeds will go towards clinical study for the firm's miniature magnetic levitation artificial heart product, and research and development (R&D) into novel products.

Core Medtech boasts in-house developed ultra-small magnetic suspension centrifugal artificial hearts, 34 mm in diameter, 26 mm in thickness, and 90 grams in weight. Studies have shown that said product has excellent blood compatibility, low risk of causing hemolysis, thrombosis, or other damage to blood cells, and has the advantages of low power consumption, strong battery life, and less heat. The product is designed to offer a permanent treatment for patients with end-stage heart failure, as a transitional treatment before heart transplantation, short-term treatment to assist heart function recovery, partial replacement of ECMO for extracorporeal circulation assistance and emergency circulation assistance treatment.

Reference:

Related news
Óscar Vicente Scavone, president of Paraguay-based Laboratorios Éticos, last week commented on the local pharmaceutical industry’s situation and prospects amid the COVID-19 pandemic.
China-based Sinocare Inc.(300298.SZ), a diabetes and other chronic disease management solutions provider, plans to inject a RMB 150 million (USD 22.25 million) financial dose into compatriot firm Shanghai Pharma Health Commerce Co., Ltd. The former will hold a 4.95% stake in the latter upon deal closure.
China’s Jiangsu Hengrui Medicine Co., Ltd (600276.SH) released its Q3 2020 financial report, with revenues up 14.57% year-on-year (YOY) during the first nine months to RMB 19.41 billion (USD 2.88 billion).
Haier Biomedical (688139.SH) is set to acquire 90% stakes in Chongqing Sanda Weiye Pharmaceutical Co., Ltd (GBI translation), a state-designated drugs and devices manufacturer.
Beijing-headquartered biotech Leto Laboratories reportedly raised more than RMB 100 million (USD 14.83 million) via a Series B financing round, funneled by Qijing Investment, Qiaojing Capital and Beijing Changping Technology Innodevelop Group.
Recent news
Mexican authorities last week revealed that the SARS-CoV-2 vaccine advanced purchases that were announced recently will include 51 million doses from the World Health Organization (WHO)’s COVAX initiative, up to 34 million of Pfizer’s double-dose immunization, 77 million of AstraZeneca (AZ)’s double-dose vaccine, and 35 million of CanSino’s single-dose treatment, totalling 197 million doses for 116.7 million people.
According to GBI analysis, Chile's Institute of Public Health (ISP) this week published the approvals of US firm Pfizer’s biosimilar Ruxience (rituximab), Netherlands-based Synthon’s Gatrel (sunitinib), a first-in-market generic version of Pfizer’s Sutent, as well as Argentina-based Varifarma’s Nibclus (ponatinib), a first-mover generic of Pint Pharma’s Iclusig.
Brazil’s Ministry of Science, Technology, Innovation and Communication (MCTIC) this week announced results of a clinical trial (CT) evaluating the efficacy of broad-range antiviral nitazoxanide against early-stage COVID-19.
Óscar Vicente Scavone, president of Paraguay-based Laboratorios Éticos, last week commented on the local pharmaceutical industry’s situation and prospects amid the COVID-19 pandemic.
China-based Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA:600196; HKG:02196) announced clinical trial approval from the US FDA for ORIN1001, a potential first-in-class treatment for idiopathic pulmonary fibrosis (IPF).
Chinese internet giant Tencent (HK.00700) trumpeted the launch of two new products in the healthcare space.
Russian bank and financial services giant Sberbank and compatriot pharma firm JSC Pharmasyntez signed a cooperation agreement on October 14, 2020.
Analytics Snapshot


Analytics Snapshot